ENGOT-OV51/NItCHE/MITO33
Trial Description:
Randomized phase III trial on NIraparib-dostarlimab vs physiscian’s choice CHEmotherapy in recurrent, platinum resistant ovarian, fallopian tube or primary peritoneal cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Recruiting
Contact person:
dlorusso